Once a final rejection has been entered in an application, there is no right to unrestricted further prosecution. However, to advance the goal of compact prosecution, the USPTO introduced a program in 2012 that outlined when...more
Time to grant is vitally important when generating a robust patent portfolio. While speed is critical for many start-ups, it often comes with a price. Track One examination requires payment of fees. And even the patent...more
Two Pilot Programs for Compact Prosecution – First Action Interview and After Final Consideration Pilot Programs -
Streamlining and accelerating patent prosecution are goals of both the USPTO and stakeholders. The USPTO has...more
This article discusses aspects of ex parte appeals of patent applications before the United States Patent and Trademark Office (USPTO). A patent applicant, whose claims have been twice rejected, may appeal an examiner’s...more
Appealing the Rejection of a Patent Application in the United States, Europe, and China -
In some circumstances, appealing the rejection of a patent application is the only practical recourse a patent applicant may have...more
7/1/2020
/ Appeals ,
Biopharmaceutical ,
CNIPA ,
European Patent Office ,
Intellectual Property Litigation ,
Intellectual Property Protection ,
Obviousness ,
Patent Applications ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
USPTO
Prosecuting Bioinformatics Patent Applications in the United States, Europe, and China -
The bioinformatics market is a multi-billion dollar industry, expecting to nearly double in a few years. However, seeking patent...more
Technology Spotlight - Patenting Blockchain Technology -
Blockchain is a booming technology, causing a dramatic increase in patent filings at the U.S Patent and Trademark Office. The November 2018 issue of Sterne Kessler’s...more
In December 2017, the Taiwan Pharmaceutical Affairs Act has been amended to harmonize generic approval process with prevailing international norms. The amended Act is expected to come into effect in late 2018 or early 2019....more
4/16/2018
/ Biobased Chemicals ,
Biologics ,
Food and Drug Administration (FDA) ,
Foreign Patent Applications ,
Generic Drugs ,
Hatch-Waxman ,
Marketing Exclusivity Periods ,
Patent Applications ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Taiwan
Patents and a New Patent Linkage System in Taiwan -
Patent protection in Taiwan is becoming of everincreasing importance as the country’s economic influence grows worldwide. The April 2018 issue of Sterne Kessler’s Global...more
Dividing a single patent application into multiple patents is often essential for deriving maximum economic benefit from the disclosed inventions. When an applicant wants to protect multiple inventions disclosed in a single...more
1/24/2018
/ Biopharmaceutical ,
Divisional Applications ,
Double Patent ,
Exclusive Licenses ,
Foreign Patent Applications ,
IP License ,
Parent Patents ,
Paris Convention ,
Patent Applications ,
Patent Filings ,
Patent Portfolios ,
Patents
Double Patenting and Divisional Applications -
Many countries allow an applicant to protect multiple inventions disclosed in a single application in one or more continuing applications. In most countries divisional...more
Worldwide Patent Term Extension Provisions -
Mechanisms to recover patent term lost during regulatory approval are available in many countries throughout the world. The August 2017 issue of Sterne Kessler’s Global Patent...more
Albania -
6 months -
Novelty/Inventive Step in Limited Circumstances -
Disclosure not to be taken into account in determining patentability if it occurred within six months before the filing date (priority date) when...more
China is in the midst of a tremendous patent boom. Worldwide, total patent application filings were up 7.8% in 2015, with China accounting for 84% of the total growth[1]. In 2015, the State Intellectual Property Office of the...more
5/17/2017
/ Animal Patents ,
China ,
Diagnostic Method ,
Filing Requirements ,
Life Sciences ,
Patent Applications ,
Patent Cooperation Treaty ,
Patent Fees ,
Patent Prosecution ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Request for Examination ,
SIPO ,
Stem cells
It should come as no surprise that the home of the Bundesautobahn has multiple mechanisms to speed up patent prosecution. And since the average pendency of a European application is approximately four years[i], patentees will...more
The March 2017 inaugural issue of Sterne Kessler's Global Patent Prosecution Newsletter includes information and practical tips for accelerated examination strategies in the United States, Europe, and Asia.
...more